Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Jump to bottom

Design, Development and Therapy: First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 #8

Open
shanmdphd opened this issue Aug 7, 2020 · 0 comments
Open

Design, Development and Therapy: First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 #8

shanmdphd opened this issue Aug 7, 2020 · 0 comments
Assignees
@shanmdphd
Labels
2020 논문 Papers

Comments

@shanmdphd
Copy link
Member

August 2020 Drug Design, Development and Therapy Volume 14:3189-3199
DOI: 10.2147/DDDT.S235802
@shanmdphd shanmdphd self-assigned this Aug 7, 2020
@shanmdphd shanmdphd changed the title First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers http://doi.org/10.2147/DDDT.S235802 Aug 7, 2020
@shanmdphd shanmdphd changed the title First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers http://doi.org/10.2147/DDDT.S235802 First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - Design, Development and Therapy - http://doi.org/10.2147/DDDT.S235802 Aug 7, 2020
@shanmdphd shanmdphd changed the title First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - Design, Development and Therapy - http://doi.org/10.2147/DDDT.S235802 Design, Development and Therapy - First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 Aug 7, 2020
@shanmdphd shanmdphd changed the title Design, Development and Therapy - First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 Design, Development and Therapy: First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 Aug 7, 2020
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Assignees

@shanmdphd shanmdphd

Labels
2020 논문 Papers
Projects
None yet
Milestone
No milestone
Development

No branches or pull requests
1 participant
@shanmdphd